Lindy Snider serves as Executive at Intiva BioPharma Inc., where they oversee executive responsibilities. Since joining the company, Lindy Snider has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 7, 2021 involved receiving (via award) 250,000 shares valued at $0.
Lindy Snider currently holds 730,000 shares of Intiva BioPharma Inc. (NTVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lindy Snider has been a net neutral trader of NTVA stock. They have purchased $0 and sold $0 worth of shares.
Lindy Snider's most recent insider trade was on Jun 7, 2021, when they sold 250,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.38 |
| Discretionary |